ATE16189T1 - Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide. - Google Patents

Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide.

Info

Publication number: ATE16189T1
Authority: AT; Austria
Prior art keywords: norhexaosyl; lacto; beta; ceramides; production
Prior art date: 1981-12-17

Application number

AT82810542T

Other languages

English (en)

Inventor

Michel Martin

Original Assignee

Lucchini Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-12-17

Filing date

1982-12-15

Publication date

1985-11-15

1982-12-15 Application filed by Lucchini Lab Sa filed Critical Lucchini Lab Sa

1985-11-15 Application granted granted Critical

1985-11-15 Publication of ATE16189T1 publication Critical patent/ATE16189T1/de

Links

229940106189 ceramide Drugs 0.000 title abstract 4
150000001783 ceramides Chemical class 0.000 title 1
239000003925 fat Substances 0.000 title 1
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 abstract 3
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 abstract 3
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 abstract 3
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 abstract 3
208000023275 Autoimmune disease Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
150000002270 gangliosides Chemical class 0.000 abstract 1
210000005059 placental tissue Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Developmental Biology & Embryology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Crystallography & Structural Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Pregnancy & Childbirth (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT82810542T 1981-12-17 1982-12-15 Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide. ATE16189T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH8056/81A CH658458A5 (fr)	1981-12-17	1981-12-17	Procede pour l'obtention du lacto-n-norhexaosyl ceramide.
EP82810542A EP0082818B1 (de)	1981-12-17	1982-12-15	Verfahren zur Herstellung von menschlichen Fetten und von Lacto-N-norhexaosyl Keramide

Publications (1)

Publication Number	Publication Date
ATE16189T1 true ATE16189T1 (de)	1985-11-15

Family

ID=4334455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT82810542T ATE16189T1 (de)	1981-12-17	1982-12-15	Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide.

Country Status (6)

Country	Link
US (1)	US4521593A (de)
EP (1)	EP0082818B1 (de)
JP (1)	JPS58110520A (de)
AT (1)	ATE16189T1 (de)
CH (1)	CH658458A5 (de)
DE (1)	DE3267065D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1168205B (it) *	1983-07-21	1987-05-20	Wellcome Italia	Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
FR2553261B1 (fr) *	1983-10-14	1986-02-21	Bio Extraction	Lait artificiel pour l'alimentation des nouveaux-nes et des jeunes enfants
IT1199116B (it) *	1984-07-03	1988-12-30	Fidia Farmaceutici	Derivati di gangliosidi
IT1182209B (it) *	1985-02-18	1987-09-30	Fidia Farmaceutici	Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
JPH0653764B2 (ja) *	1985-07-31	1994-07-20	三井東圧化学株式会社	モノシアロガングリオシドの製造法
FR2596988B1 (fr) *	1986-04-14	1990-06-08	Merieux Inst	Procede de preparation de lipides riches en acides gras polyinsatures a longue chaine
US5164298A (en) *	1988-06-24	1992-11-17	Hsc Research Development Corporation	Verocytotoxin receptor assay
CH677494A5 (de) *	1988-10-28	1991-05-31	Nestle Sa
US5532141A (en) *	1995-06-13	1996-07-02	Holler; Larry D.	Process for obtaining ganglioside lipids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1692566A1 (de) *	1967-04-18	1971-08-05	Unilever Nv	Verfahren zur Herstellung von partiell hydrolysierten Pflanzenphosphatiden mit verbesserter Emulgierwirkung
AT315359B (de) *	1972-07-31	1974-05-27	Etapharm Chem Pharm Lab Ges M	Verfahren zur Herstellung von hochgereinigten Phosphatiden aus tierischen Organen
JPS57500609A (de) *	1980-05-09	1982-04-08

1981
- 1981-12-17 CH CH8056/81A patent/CH658458A5/fr not_active IP Right Cessation
1982
- 1982-12-15 US US06/450,183 patent/US4521593A/en not_active Expired - Fee Related
- 1982-12-15 DE DE8282810542T patent/DE3267065D1/de not_active Expired
- 1982-12-15 EP EP82810542A patent/EP0082818B1/de not_active Expired
- 1982-12-15 AT AT82810542T patent/ATE16189T1/de not_active IP Right Cessation
- 1982-12-16 JP JP57221056A patent/JPS58110520A/ja active Pending

Also Published As

Publication number	Publication date
JPS58110520A (ja)	1983-07-01
CH658458A5 (fr)	1986-11-14
DE3267065D1 (en)	1985-11-28
US4521593A (en)	1985-06-04
EP0082818B1 (de)	1985-10-23
EP0082818A1 (de)	1983-06-29

Similar Documents

Publication	Publication Date	Title
DE3856594D1 (de)	2008-11-27	Mittel zur behandlung der alzheimer-krankheit
DE3852275D1 (de)	1995-01-12	Ultraschallsonde für intravaskulären Katheter zur Behandlung intravaskulärer Verschlüsse.
DE59003771D1 (de)	1994-01-20	Verfahren zur Herstellung von cyclischen Aminosäurederivaten sowie Zwischenprodukte.
DE3855921D1 (de)	1997-07-03	Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein
DE3855525D1 (de)	1996-10-17	Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
ATE96174T1 (de)	1993-11-15	Verfahren zur herstellung von avermectine-b und die verwendeten kulturen.
DK43890D0 (da)	1990-02-19	Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
ATE16189T1 (de)	1985-11-15	Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide.
ATE3866T1 (de)	1983-07-15	Verfahren zur herstellung einer kollagenloesung, eine solche loesung sowie ihre verwendung.
ATE1195T1 (de)	1982-07-15	Neues ubiquitaeres gewebsprotein pp8 und verfahren zu seiner anreicherung.
HUT40436A (en)	1986-12-28	Process for production pirrolo-benzimidasoles and medical preparatives containing thereof
DE3468021D1 (en)	1988-01-21	Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same
EP0117064A3 (en)	1985-04-17	Process for heat treatment of blood coagulation factor viii
DE69130679D1 (de)	1999-02-04	Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3587681D1 (de)	1994-01-27	Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
PT83309B (de)	1988-01-11	Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
DK317285D0 (da)	1985-07-11	Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf
IT8721115A0 (it)	1987-06-30	Fitopreparato per la cura di affezioni cutanee.
ES2167322T3 (es)	2002-05-16	Proteina de tipo cadherinico relacionada con los huesos y procedimiento para su preparacion.
ATE15050T1 (de)	1985-09-15	Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
DE3884324D1 (de)	1993-10-28	Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
ATE37873T1 (de)	1988-10-15	Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
ZA872863B (en)	1987-10-13	1,4-dihydropyridine derivatives,process for their preparation and medicaments containing these compounds
SE8204625D0 (sv)	1982-08-09	Method for stimulating the synthesis of the melanotic pigment of the skin
ATE82075T1 (de)	1992-11-15	Verfahren und ausruestung zur herstellung von radioaktivmarkierten antikoerpern fuer die in-vivo- krebsdiagnose und therapie.

Legal Events

Date	Code	Title	Description
1986-03-15	UEP	Publication of translation of european patent specification
1991-09-15	REN	Ceased due to non-payment of the annual fee